COMPOUND PROFILE / PROTEINS & BIOLOGICS
HGH 191AA / Somatropin.
Research draftHGH 191AA refers to the 191-amino-acid human growth-hormone sequence; approved recombinant versions are somatropin.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Identity and evidence review notes
Confirm exact identity, sequence, alias or formulation before attaching product-specific evidence.
Overview
HGH 191AA refers to the 191-amino-acid human growth-hormone sequence; approved recombinant versions are somatropin.
Mechanism
Somatropin activates growth-hormone receptors and downstream IGF-1 signalling.
Human research
Clinical evidence supports particular deficiency and growth-disorder indications. It does not establish healthy-user longevity benefit.
Preclinical & other research
Mechanistic growth research is extensive but does not authenticate a supplier's vial.
Safety & unknowns
Fluid retention, joint symptoms and glucose effects are relevant; approved-product warnings apply.
Regulatory status
Keep this market-labelled entry linked to Somatropin, while treating supplier authenticity separately.
Reported use & evidence
The supplied HGH 191AA / Somatropin profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.